<html>
<head>PUBMED IDs for PPP2R5B</head>
<body bgcolor='#C5F0F2'><h1>PPP2R5B</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9286704/'>Construction of a 1.2-Mb sequence-ready contig of chromosome 11q13 encompassing the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1.</a> August 15  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9272177/'>Mapping of the gene encoding the B56 beta subunit of protein phosphatase 2A (PPP2R5B) to a 0.5-Mb region of chromosome 11q13 and its exclusion as a candidate gene for multiple endocrine neoplasia type 1 (MEN1).</a> September 1  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/16276521/'>The glycine 90 to aspartate alteration in the Abeta subunit of PP2A (PPP2R1B) associates with breast cancer and causes a deficit in protein function.</a> November 9  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17187232/'>Mutation analysis of five candidate genes in familial breast cancer.</a> December 26  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/21600320/'>A de novo 0.57 Mb microdeletion in chromosome 11q13.1 in a patient with speech problems, autistic traits, dysmorphic features and multiple endocrine neoplasia type 1.</a> November 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/25972378/'>Mutations in the PP2A regulatory subunit B family genes PPP2R5B, PPP2R5C and PPP2R5D cause human overgrowth.</a> May 12  2015<br></body></html>
